Biodegradable drains for medical applications
The invention relates, generally, to medical appliances. More particularly, it relates to tubular shaped devices used as drains for draining fluids (liquids and/or gases) from antrums or other parts of the human or animal body. According to the present invention a drain is provided, which is suitable for draining a human or animal antrum, which drain comprises a synthetic biodegradable material, preferably a biodegradable polymer.
1. Drain suitable for draining a human or animal antrum, organ or tissue, characterized in that it comprises an elastic biocompatible, biodegradable synthetic thermoplastic non-chemically-crosslinked polymer, which polymer has at least one softening point of at most mammalian body temperature and an elastic modulus of up to 120 MPa,
wherein the biodegradable polymer comprises at least one of a polyester, polycarbonate, polyester-carbonate, polyanhydride, polyurethane or polyamide which are optionally combined with polyether groups,
wherein the polyester is a random DL-Lactide-ε-caprolactone copolyester, having a lactide content of 20-75 mol % and
the optional polyether is polyethyleneglycol, polypropyleneglycol, copolymers of polyethyleneglycol and polypropyleneglycol or polytetramethyleneoxide (PTMO).
2. Drain according to claim 1 , consisting essentially of said synthetic biodegradable polymer.
3. Drain according to claim 1 , wherein the polymer has at least one softening point (glass transition temperature) of at most 37-° C.
4. Drain according to claim 1 , wherein the fraction of the L-enantiomer or the D-enantiomer of the lactide is from 65-95 mol.
5. Drain according to claim 1 , wherein the polyester, polyester-carbonate and/or polyanhydride is a segmented or block copolymer with randomly or alternating segments or blocks and consisting of at least two blocks with different composition.
6. Drain according to claim 5 , wherein the segments or blocks are phase separated hard and soft segments, characterized by at least two phase transitions, one of them being a glass transition temperature lower than 37-° C., the other a glass transition temperature or melting temperature higher than 37-° C.
7. Drain according to claim 5 , wherein the segments or blocks forming the low temperature transition phase are composed of pre-polymers of or mixtures of cyclic or non-cyclic monomers lactide, glycolide, ε-caprolactone, δ-valerolactone, trimethylenecarbonate, tetramethylenecarbonate, 1,5-dioxepane-2-one, para-dioxanone and/or hydroxyalkanoicacid.
8. Drain according to claim 5 , wherein the copolymer or pre-polymers are obtained by a ring opening polymerization initiated by a diol or di-acid compound.
9. Drain according to claim 5 , wherein the pre-polymers forming the segments are linked by a difunctional aliphatic compound, preferably a diisocyanate, more preferably 1,4-butanediisocyanate.
10. Drain according to claim 6 , wherein the hard segment or block is selected from the group consisting of poly-caprolactone, poly-valerolactone, poly-lactide, poly(lactide-glycolide), poly-para-dioxanone, poly (hydroxybutyricacid), polysebacic acid, poly(dodecanedioicanhydride) pre-polymers, and combinations thereof.
11. Drain according to claim 1 , wherein said polymer is loaded with radiopaque fillers or pharmaceutical components comprising antibiotics, anti-inflammatory agents, peptides and proteins.
12. Drain according to claim 1 , which is provided with perforations.
13. Nasal drain comprising an elastic biocompatible, biodegradable synthetic thermoplastic non-crosslinked polymer, wherein the polymer has at least one softening point of at most mammalian body temperature and an elastic modulus of up to 120 MPa,
wherein the biodegradable polymer comprises at least one of a polyester, polycarbonate, polyester-carbonate, polyanhydride, polyurethane or polyamide which are optionally combined with polyether groups,
wherein the polyester is a random DL-Lactide-ε-caprolactone copolyester, having a lactide content of 20-75 mol %, and
the optional polyether is polyethyleneglycol, polypropyleneglycol, copolymers of polyethyleneglycol and polypropyleneglycol or polytetramethyleneoxide (PTMO).
14. Drain, being a nasal drain, according to claim 1 , having a wall thickness of 0.05-5.0 mm.
15. Drain according to claim 1 , having a total length of 3-300 mM.
16. Drain according to claim 1 , having an outer diameter of 0.5-50 mm.
17. Drain according to claim 1 , comprising a funnel shaped element on at least one end.
18. Drain according to claim 17 , having a funnel length of 2-20 mm and a funnel diameter of 3-30 mm.
19. Drain according to claim 1 , which is obtainable by dip-coating or spray coating of a polymer solution on a mandrel or extrusion of a polymer.
20. Method for treating a disorder associated with dysfunction of natural drainage of body fluids from an antrum, organ or tissue comprising introducing a drain according to claim 1 in said antrum, organ or tissue, such that said antrum, organ or tissue is connected with the environment or another location within the body, after which said drain degrades over time and degradation products of said drain are cleared through the digestive channel or said antrum, organ or tissue or absorbed and subsequently metabolized or secreted by the body.
21. Method according to claim 20 , wherein said disorder is selected from (chronic) sinusitis, inflammation of the middle ear, liver disorders, disorders of the gastro-intestinal tract, tear duct disorder, surgical wound drainage, and thoracic disorder.
22. Method according to claim 20 , wherein said drain is introduced in said antrum using at least one of a form of attachment selected from the group consisting of sealant, suture, and staple.
23. The method of claim 20 , comprising performing coloanal anastomosis performing coloanal anastomosis.